OBJECTIVE: To examine trends in opioid poisonings and adverse effects in Washington (WA) State and nationally. METHODS: We calculated rates of opioid poisonings and adverse effects and examined opioid prescriptions in the WA workers' compensation system, 2004-2010. Using Health Care Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS) data, we also calculated national rates of opioid poisonings and adverse effects, 1993-2010. RESULTS: We identified 96 opioid poisonings and 312 opioid-related adverse effects in WA, 2004-2010. The rates did not change substantially over these years. Most poisonings and adverse effects occurred in cases without chronic opioid use and with prescribed doses <120 mg/day morphine-equivalent dose. Nationally, the rates of opioid poisonings and adverse effects increased significantly from 1993 to 2010. CONCLUSIONS: Many poisonings and adverse effects occurred in patients without high dose or long-term opioid therapy, suggesting that opioid dosing and duration guidelines may not be sufficient to reduce morbidity related to prescription opioid use.
OBJECTIVE: To examine trends in opioid poisonings and adverse effects in Washington (WA) State and nationally. METHODS: We calculated rates of opioid poisonings and adverse effects and examined opioid prescriptions in the WA workers' compensation system, 2004-2010. Using Health Care Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS) data, we also calculated national rates of opioid poisonings and adverse effects, 1993-2010. RESULTS: We identified 96 opioid poisonings and 312 opioid-related adverse effects in WA, 2004-2010. The rates did not change substantially over these years. Most poisonings and adverse effects occurred in cases without chronic opioid use and with prescribed doses <120 mg/day morphine-equivalent dose. Nationally, the rates of opioid poisonings and adverse effects increased significantly from 1993 to 2010. CONCLUSIONS: Many poisonings and adverse effects occurred in patients without high dose or long-term opioid therapy, suggesting that opioid dosing and duration guidelines may not be sufficient to reduce morbidity related to prescription opioid use.
Authors: Jeanne M Sears; Deborah Fulton-Kehoe; Beryl A Schulman; Sheilah Hogg-Johnson; Gary M Franklin Journal: Public Health Rep Date: 2019-07-31 Impact factor: 2.792
Authors: Enihomo Obadan-Udoh; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Ulrike Muench; Matthew Jura; Hyunjee Kim; Eli Schwarz; Elizabeth Mertz; Benjamin C Sun Journal: J Am Dent Assoc Date: 2019-04 Impact factor: 3.634
Authors: Jeanne M Sears; Sheilah Hogg-Johnson; Ryan A Sterling; Deborah Fulton-Kehoe; Gary M Franklin Journal: Occup Environ Med Date: 2020-04-10 Impact factor: 4.402
Authors: Manu Thakral; Rod L Walker; Kathleen Saunders; Susan M Shortreed; Sascha Dublin; Michael Parchman; Ryan N Hansen; Evette Ludman; Karen J Sherman; Michael Von Korff Journal: Pain Med Date: 2018-12-01 Impact factor: 3.750
Authors: Adeleke D Adewumi; Samantha A Hollingworth; Joemer C Maravilla; Jason P Connor; Rosa Alati Journal: CNS Drugs Date: 2018-02 Impact factor: 5.749
Authors: Gary Franklin; Jennifer Sabel; Christopher M Jones; Jaymie Mai; Chris Baumgartner; Caleb J Banta-Green; Darin Neven; David J Tauben Journal: Am J Public Health Date: 2015-01-20 Impact factor: 9.308